Global $12.14 Billion Osteoarthritis (IA Injections, NSAIDs & Analgesics) Markets, Insights, Trends & Forecasts, 2022-2026 – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “Global Osteoarthritis Market (IA Injections, NSAIDs & Analgesics): Insights, Trends & Forecast (2022-2026)” report has been added to ResearchAndMarkets.com’s offering.

The global osteoarthritis market revenues are forecasted to touch US$12.14 billion in 2026, growing at a CAGR of 9.84% for the period spanning 2022 to 2026.

Factors such as increasing occurrence of osteoarthritis, growing geriatric population, rising healthcare expenditure per capita, growing obese population and improving consumer confidence index are expected to drive the market growth.

However, growth of the industry would be challenged by associated business risk, patient health-associated risk and stringent regulations. A few notable trends include growth in pharmaceutical R&D expenditures, progressing product pipeline, advancement in osteoarthritis treatments and growth in online pharmaceutical sales.

The global osteoarthritis market by treatment type is segmented into categories i.e. IA Injections (corticosteroids and HA) and Drugs (NSAIDs & Analgesics). Among them, IA injections held the largest share of the industry revenues due to growth in prevalence of joint disorders across the world.

The fastest growing regional market is North America. The growth was supported by growth in geriatric population, surge in HA injections demand, rise in sports injuries and development in e-commerce industry. The U.S. is the largest market and is already well-penetrated at developed market levels.

The company profiles of leading players i.e. Johnson & Johnson, Novartis AG, Bayer AG, GlaxoSmithKline Plc, Pfizer Inc. and Sanofi S.A. are also presented in detail.

Key Topics Covered:

1. Market Overview

1.1 Introduction

1.2 Causes

1.3 Symptoms

1.4 Diagnosis

1.5 Treatment

2. Global Osteoarthritis Market Analysis

2.1 Global Osteoarthritis Market Value

2.2 Global Osteoarthritis Market Value Forecast

2.3 Global Osteoarthritis Market Value by Anatomy Type

2.3.1 Global Knee Osteoarthritis Market Value

2.3.2 Global Knee Osteoarthritis Market Value Forecast

2.3.3 Global Knee Osteoarthritis Market Value by Region

2.4 Global Osteoarthritis Market Value by Treatment Type

2.4.1 Global Osteoarthritis IA Injections Market Value

2.4.2 Global Osteoarthritis IA Injections Market Value Forecast

2.4.3 Global Osteoarthritis Drugs Market Value

2.4.4 Global Osteoarthritis Drugs Market Value Forecast

2.4.5 Global Osteoarthritis Drugs Market Value by Type

2.4.6 Global Osteoarthritis NSAIDs Market Value

2.4.7 Global Osteoarthritis NSAIDs Market Value Forecast

2.4.8 Global Osteoarthritis Analgesics Market Value

2.4.9 Global Osteoarthritis Analgesics Market Value Forecast

2.4.10 Global Osteoarthritis Drugs Market Value by Route of Administration

2.4.11 Global Osteoarthritis Parenteral Drugs Market Value

2.4.12 Global Osteoarthritis Parenteral Drugs Market Value Forecast

2.4.13 Global Osteoarthritis Oral Drugs Market Value

2.4.14 Global Osteoarthritis Oral Drugs Market Value Forecast

2.5 Global Osteoarthritis Market Value by Distribution Channels

2.6 Global Osteoarthritis Market Value by Region

3. Regional Osteoarthritis Market Analysis

3.1 North America

3.1.1 North America Osteoarthritis Market Value

3.1.2 North America Osteoarthritis Market Value Forecast

3.1.3 North America Osteoarthritis Market Value by Anatomy Type

3.1.4 North America Knee Osteoarthritis Market Value

3.1.5 North America Knee Osteoarthritis Market Value Forecast

3.1.6 North America Osteoarthritis Market Value by Country

3.1.7 The U.S. Osteoarthritis Market Value

3.1.8 The U.S. Osteoarthritis Market Value Forecast

3.1.9 The U.S. Osteoarthritis Market Value by Treatment Type

3.1.10 The U.S. Osteoarthritis IA Injections Market Value

3.1.11 The U.S. Osteoarthritis IA Injections Market Value Forecast

3.1.12 The U.S. Osteoarthritis Drugs Market Value

3.1.13 The U.S. Osteoarthritis Drugs Market Value Forecast

3.1.14 The U.S. Osteoarthritis Drugs Market Value by Type

3.1.15 The U.S. Osteoarthritis NSAIDs Market Value

3.1.16 The U.S. Osteoarthritis NSAIDs Market Value Forecast

3.1.17 The U.S. Osteoarthritis Analgesics Market Value

3.1.18 The U.S. Osteoarthritis Analgesics Market Value Forecast

3.2 Europe

3.3 Asia-Pacific

4. Market Dynamics

4.1 Growth Drivers

4.1.1 Inclining Occurrence of Osteoarthritis

4.1.2 Growing Geriatric Population

4.1.3 Rising Healthcare Expenditure per Capita

4.1.4 Growing Obese Population

4.1.5 Improving Consumer Confidence Index

4.2 Key Trends and Developments

4.2.1 Growth in Pharmaceutical R&D Expenditures

4.2.2 Progressing Product Pipeline

4.2.3 Advancement in Osteoarthritis Treatments

4.2.4 Growth in Online Pharmaceutical Sales

4.3 Challenges

4.3.1 Associated Business Risk

4.3.2 Patient Health-Associated Risk

4.3.3 Stringent Regulations

5. Company Profiles

• Sanofi S.A.
• Pfizer Inc.
• Bayer AG
• Novartis AG
• Johnson & Johnson

For more information about this report visit https://www.researchandmarkets.com/r/vr8p5

Contacts

ResearchAndMarkets.com

Laura Wood, Senior Press Manager

[email protected]
For E.S.T Office Hours Call 1-917-300-0470

For U.S./CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900